financetom
HLVX
financetom
/
Healthcare
/
HLVX
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
HilleVax, Inc.HLVX
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
80.48M
Revenue (ttm)
n/a
Net Income (ttm)
-147.27M
Shares Out
49.22M
EPS (ttm)
-3.00
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
193,040
Open
1.570
Previous Close
1.550
Day's Range
1.570 - 1.700
52-Week Range
1.340 - 16.310
Beta
0.86
Analysts
Hold
Price Target
2.33 (+42.51%)
Earnings Date
May 8, 2025
Description >

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines.

The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness.

The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021.

HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Copyright 2023-2025 - www.financetom.com All Rights Reserved